SCHEMBL6950944

SCHEMBL6950944

CCOc1nc(CCOC2CCCCO2)nc(N2CCc3ccccc3CC2)c1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.41
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
SQOR Q9Y6N5 1/20 0.35
KDM4E B2RXH2 7/20 0.35
IDH1 O75874 3/20 0.34
ALDH1A1 P00352 5/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 3/20 0.33
RPS27 P42677 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HTT P42858 2/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948526 0.91 KDM4C (0.40) KDM4CNPC1RAB9AL3MBTL1KDM4E
SCHEMBL6948613 0.91 KDM4C (0.40) KDM4CNPC1RAB9AL3MBTL1KDM4E
SCHEMBL6953594 0.84 PIK3CD (0.36) KDM4CL3MBTL1KDM4EIDH1ALDH1A1
SCHEMBL6957600 0.81 KDM4C (0.39) KDM4CNPC1RAB9AL3MBTL1KDM4E
SCHEMBL6945144 0.79 HRH4 (0.40) RAB9AL3MBTL1SQORKDM4EALDH1A1
SCHEMBL6953035 0.78 KDM4C (0.40) KDM4CNPC1RAB9AL3MBTL1KDM4E
SCHEMBL6951221 0.78 SQOR (0.41) RAB9ASQORKDM4EALDH1A1MAPT
SCHEMBL6950695 0.76 KDM4C (0.38) KDM4CNPC1RAB9AL3MBTL1KDM4E
SCHEMBL6955400 0.74 PIK3CD (0.38) RAB9AL3MBTL1SQORKDM4EALDH1A1
SCHEMBL6957783 0.74 HRH4 (0.44) NPC1RAB9AL3MBTL1SQORKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed